-
Mashup Score: 0Alopecia – New building blocks - 44 minute(s) ago
Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given recent advances in the field, there has never been a more pressing time to reevaluate and improve upon the significant clinical skills needed to accurately diagnose and treat our patients with hair loss. This CME activity on alopecia is designed to (1) educate dermatologists in a simple, succinct fashion on the identification of, and the distinction between, the diverse types of hair loss and (2) discuss how to manage them.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 33
Traction alopecia (TA) is associated with wearing tight hair styles, particularly relevant to those of African descent.1 TA initiation can begin prior to symptom onset and in conjunction with other alopecias. Though initially reversible, intervention is necessary to prevent permanent hair loss. Therefore, specific findings that can identify early TA will be useful for the dermatologist.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
Resembling a torch, the flambeau sign is a trichoscopic finding indicative of fibrosis in traction alopecia (TA). The affected area of traction shows linear white tracks in the direction of hair pull. https://t.co/dLweDAvKrb https://t.co/wg28fisO0Y
-
-
Mashup Score: 5Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy - 26 day(s) ago
The breadth of therapeutic options for the management of dermatologic skin conditions continues to expand rapidly as exemplified by biologics and small molecule drug development. While dermatologists and health care providers are aware of the underlying mechanisms and indications for these therapeutics, there is a recognized practice gap due to an incomplete understanding of the safety of these medications in women of childbearing age during the prepartum, antepartum, and postpartum phases. Although a two-part continuing medical education review was published regarding the prescribing practices and safety profiles of these new therapeutics in women of childbearing age while pregnant or lactating in 2014, many new medications have been approved since then.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
While the breadth of therapeutic options for the management of skin conditions continues to expand, the gap remains in the understanding of the safety of medications on those of childbearing age during the prepartum, antepartum, and postpartum phases. https://t.co/CsgEKIhTBt https://t.co/fl13CbLi49
-
-
Mashup Score: 18Evoked piloerection sign/pseudo-Darier sign: A clinical clue to the diagnosis of cutaneous leiomyomas - 1 month(s) ago
To the Editor: Cutaneous leiomyomas (CLs) are a hallmark for hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome, caused by a pathogenic variant in the fumarate hydratase (FH) gene.1 While CLs are the most common and the earliest presenting features of HLRCC, they are often missed or misdiagnosed as scars/benign cutaneous tumors resulting in a delayed diagnosis of HLRCC and thereby, in a missed window of opportunity to initiate the screening for aggressive FH- renal cell carcinoma.2 We aimed to assess whether CLs of patients with HLRCC display an evoked transient piloerection sign (ETPS)/pseudo-Darier sign and whether ETPS can improve the clinical diagnosis of CLs.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
While cutaneous leiomyomas (CLs) are the most common feature of HLRCC, they are often misdiagnosed as scars/cutaneous tumors, which can lead to a delayed diagnosis and further missed screening opportunities. Read more of this research here - https://t.co/e8q1D11tGy https://t.co/3WPxuz1TAZ
-
-
Mashup Score: 7Alopecia – New building blocks - 1 month(s) ago
Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given recent advances in the field, there has never been a more pressing time to reevaluate and improve upon the significant clinical skills needed to accurately diagnose and treat our patients with hair loss. This CME activity on alopecia is designed to (1) educate dermatologists in a simple, succinct fashion on the identification of, and the distinction between, the diverse types of hair loss and (2) discuss how to manage them.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
This CME activity on #alopecia is designed to educate dermatologists and primary care providers on the identification of, and the distinction between, the diverse types of hair loss and discuss how to manage them. https://t.co/V1lWMiF0uM https://t.co/wwwRKlqEUY
-
-
Mashup Score: 5Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy - 1 month(s) ago
The breadth of therapeutic options for the management of dermatologic skin conditions continues to expand rapidly as exemplified by biologics and small molecule drug development. While dermatologists and health care providers are aware of the underlying mechanisms and indications for these therapeutics, there is a recognized practice gap due to an incomplete understanding of the safety of these medications in women of childbearing age during the prepartum, antepartum, and postpartum phases. Although a two-part continuing medical education review was published regarding the prescribing practices and safety profiles of these new therapeutics in women of childbearing age while pregnant or lactating in 2014, many new medications have been approved since then.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
While the breadth of therapeutic options for the management of skin conditions continues to expand, the gap remains in the understanding of the safety of medications on those of childbearing age during the prepartum, antepartum, and postpartum phases. https://t.co/CsgEKIhTBt https://t.co/fl13CbLi49
-
-
Mashup Score: 1
Chronic pruritus is a highly prevalent disease associated with high psychosocial and economic burdens. In addition to pharmacological treatments, device-based physical therapies also offer antipruritic effects. Phototherapy, laser, electrical neurostimulation technologies, acupuncture, cryotherapy, and cold atmospheric plasma are, in part, still experimental but emerging treatment options that augment our repertoire to treat patients with chronic pruritus. In this narrative review, we provided an overview of these physical modalities and their role in itch management.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
Chronic pruritus is a disease that impairs patients' quality of life and may lead to psychosocial and health-economic burdens. Both device-based and non-device physical counterstimuli treatments, and experimental but emerging treatments are reviewed. https://t.co/ADeVfO8QZr https://t.co/yxcJ014dSq
-
-
Mashup Score: 7Alopecia – New building blocks - 2 month(s) ago
Hair loss is devastating to the patient, but the diagnosis and treatment of alopecia are also difficult for primary care providers and even dermatologists. Given recent advances in the field, there has never been a more pressing time to reevaluate and improve upon the significant clinical skills needed to accurately diagnose and treat our patients with hair loss. This CME activity on alopecia is designed to (1) educate dermatologists in a simple, succinct fashion on the identification of, and the distinction between, the diverse types of hair loss and (2) discuss how to manage them.
Source: www.jaad.orgCategories: General Medicine News, Partners & KOLsTweet-
This CME activity on #alopecia is designed to educate dermatologists and primary care providers on the identification of, and the distinction between, the diverse types of hair loss and discuss how to manage them. https://t.co/V1lWMiF0uM https://t.co/wwwRKlqEUY
-
-
Mashup Score: 8
Dupilumab effectively treats atopic dermatitis (AD); however, its role in halting the atopic march remains uncertain.
Source: www.jaad.orgCategories: General Medicine News, Allergy-ImmunologyTweet-
Reduced #atopic #march risk in pediatric #atopic #dermatitis patients prescribed #dupilumab versus conventional immunomodulatory therapy: A population-based cohort study. https://t.co/D2oXo2BYuu https://t.co/01RDeyh0G5
-
-
Mashup Score: 10
AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
Source: www.jaad.orgCategories: General Medicine News, DermatologyTweet-
A recently published @JAADjournals supplement called “Alopecia: A New Frontier” can help dermatologists differentiate between the various types of #alopecia, identify correct treatments, and earn up to 8 CME credits. https://t.co/JCUW7D1SlV https://t.co/sY1yZI2VRM
-
This CME activity on #alopecia is designed to educate dermatologists and primary care providers on the identification of, and the distinction between, the diverse types of hair loss and discuss how to manage them. https://t.co/V1lWMiF0uM https://t.co/wwwRKlqEUY